Preclinical CRO Market by Service and End User - Global Industry Analysis and Forecast to 2023

Published On : January 2018 Pages : 100 Category: Pharmaceuticals Report Code : HC01445

Industry Trend Analysis

The global Preclinical CRO market was worth USD 2.80 billion in 2014 and is expected to reach approximately USD 5.84 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.50% during the forecast period. Rising focus of life science companies on their core abilities combined with ascend in outsourcing of noncore capacities are additionally anticipated that would add to the development of preclinical CROs market. There has been a considerable ascent in R&D spending plan for beginning late -stage and early-stage drug improvement procedures, which is additionally anticipated that would add to the market growth. According to a report by the Servier Research Institute, 50.0% disappointments in preclinical stage are because of issues amid nonclinical toxicology testing. The expansion in disappointment because of toxicology tests is relied upon to impel the interest for preclinical CROs, in this manner adding to the worldwide preclinical CRO market.

Preclinical CRO Market

Service Type Outlook and Trend Analysis

The service portion is classified into bioanalysis, toxicology testing, DMPK studies and other preclinical services. Toxicology testing held the biggest share in the worldwide preclinical CROs market and is foreseen to rule the fragment over the gauge time frame. Toxicology testing is a huge part of Investigational New Drug (IND)- empowering considers in the United States. The ascent in outsourcing of noncore preclinical investigations to CROs and the developing capacities of CROs to offer extra value add services are foreseen to drive the market over the gauge time frame.

End User Outlook and Trend Analysis

The end-use section of preclinical CRO market incorporates government, medicinal device companies, academic institutes and biopharmaceutical organizations. Biopharmaceutical organizations are the biggest end-use section of the preclinical CRO market. This fragment is anticipated to rule the preclinical CRO market amid the conjecture time frame. This is inferable from increment in pattern of outsourcing end-to-end services, particularly among the little and moderate size biopharmaceutical organizations that need adequate skill in preclinical period of medication advancement.

Regional Outlook and Trend Analysis

North America held the biggest share in the worldwide preclinical CRO market and is foreseen to command the market over the figure time frame. Existence of set up beginning time improvement CROs, for example, Charles River Laboratories and LabCorp; better nature of work; set up logical experience and intuition. The changing plan of action of MNC's outsourcing and increasing expense of R&D are foreseen to have brought about a preclinical outsourcing pattern in areas, for example, Asia Pacific, attributable to the cost-proficiency of CROs in nations, for example, China and India. Asia Pacific is foreseen to witness the quickest development in the worldwide preclinical CRO market.

Competitive Insights

The leading players in the market are PAREXEL, Charles River Laboratories, Envigo, LabCorp, Eurofins Scientific, PRA Health Sciences and Pharmaceutical Product Development. Life science companies are switching from a functional to strategic outsourcing model, and this shift is foreseen to raise the demand for big CROs providing end-to-end preclinical services.

The Preclinical CRO Market is segmented as follows-

By Type:

  • Toxicology testing
  • Bioanalysis and DMPK studies
  • Other preclinical services

By End User:

  • Biopharmaceutical companies
  • Medical device companies
  • Government and academic institutes

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

 

Market Classification

  • Preclinical CRO Market, By Service, Estimates and Forecast, 2014-2023 ($Million)
    • Bioanalysis and DMPK studies
    • Toxicology testing
    • Other preclinical services
  • Preclinical CRO Market, By End Users, Estimates and Forecast, 2014-2023 ($Million)
    • Biopharmaceutical companies
    • Government and academic institutes
    • Medical device companies
  • Preclinical CRO Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
    • North America
  • North America  Preclinical CRO Market, By Country
  • North America  Preclinical CRO Market, By Service
  • North America  Preclinical CRO Market, By End Users
    • U.S.  Preclinical CRO Market, By Service
    • U.S. Preclinical CRO Market, By End Users
    • Canada  Preclinical CRO Market, By Service
    • Canada  Preclinical CRO Market, By End Users
    • Mexico  Preclinical CRO Market, By Service
    • Mexico  Preclinical CRO Market, By End Users
    • Europe
  • Europe Preclinical CRO Market, By Country
  • Europe Preclinical CRO Market, By Service
  • Europe Preclinical CRO Market, By End Users
    • Germany  Preclinical CRO Market, By Service
    • Germany  Preclinical CRO Market, By End Users
    • France Preclinical CRO Market, By Service
    • France Preclinical CRO Market, By End Users
    • UK   Preclinical CRO Market, By Service
    • UK   Preclinical CRO Market, By End Users
    • Italy   Preclinical CRO Market, By Service
    • Italy   Preclinical CRO Market, By End Users
    • Spain   Preclinical CRO Market, By Service
    • Spain   Preclinical CRO Market, By End Users
    • Rest of Europe   Preclinical CRO Market, By Service
    • Rest of Europe   Preclinical CRO Market, By End Users
    • Asia-Pacific
      • Asia-Pacific   Preclinical CRO Market, By Country
      • Asia-Pacific   Preclinical CRO Market, By Service
      • Asia-Pacific   Preclinical CRO Market, By End Users
        • Japan   Preclinical CRO Market, By Service
        • Japan   Preclinical CRO Market, By End Users
        • Australia   Preclinical CRO Market, By Service
        • Australia   Preclinical CRO Market, By End Users
        • India   Preclinical CRO Market, By Service
        • India   Preclinical CRO Market, By End Users
        • South Korea   Preclinical CRO Market, By Service
        • South Korea   Preclinical CRO Market, By End Users
        • Rest of Asia-Pacific   Preclinical CRO Market, By Service
        • Rest of Asia-Pacific   Preclinical CRO Market, By End Users
    • Rest of the World
      • Rest of the World   Preclinical CRO Market, By Country
      • Rest of the World   Preclinical CRO Market, By Service
      • Rest of the World   Preclinical CRO Market, By End Users
        • Brazil   Preclinical CRO Market, By Service
        • Brazil   Preclinical CRO Market, By End Users
        • South Africa   Preclinical CRO Market, By Service
        • South Africa   Preclinical CRO Market, By End Users
        • Saudi Arabia   Preclinical CRO Market, By Service
        • Saudi Arabia   Preclinical CRO Market, By End Users
        • Turkey   Preclinical CRO Market, By Service
        • Turkey   Preclinical CRO Market, By End Users
        • United Arab Emirates   Preclinical CRO Market, By Service
        • United Arab Emirates   Preclinical CRO Market, By End Users
        • Others   Preclinical CRO Market, By Service
        • Others   Preclinical CRO Market, By End Users

Table of Contents

1.      Introduction

1.1.      Report Description

1.2.      Research Methodology

2.      Executive Summary

2.1.      Key Highlights

3.      Market Overview

3.1.      Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2.      Market Dynamics

3.2.1. Drivers

3.2.1.1.   Increase in R&D Budget for Early Stage and Late-stage Drug Development Processes

3.2.1.2.   Increasing  Preclinical Pipeline for Indications Such as Cancer and Orphan diseases

3.2.2. Restraints

3.2.2.1.   High Price of Preclinical CRO Testing

3.2.3. Opportunities

3.2.3.1.   Emerging Markets to Offer Lucrative Growth Opportunities

4.      Preclinical CRO Market, By Service

4.1.      Introduction

4.2.      Preclinical CRO Market   Assessment and Forecast, By Service, 2014-2023

4.3.      Bioanalysis and DMPK studies

4.3.1. Market Assessment and Forecast, By Region, 2014-2023($Million)

4.4.      Toxicology testing

4.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.      Other Preclinical Services

4.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)

5.      Preclinical CRO Market, By End User

5.1.      Introduction

5.2.      The Preclinical CRO Market   Assessment and Forecast, By End User, 2014-2023

5.3.      Biopharmaceutical companies

5.3.1. Market Assessment and Forecast, By Region, 2014-2023($Million)

5.4.      Government and academic institutes

5.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)

5.5.      Medical device companies

5.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)

6.      Preclinical CRO Market, By Region

6.1.      Introduction

6.2.      Preclinical CRO Market   Assessment and Forecast, By Service, 2014-2023($Million)

6.3.      Preclinical CRO Market   Assessment and Forecast, By End User , 2014-2023($Million)

6.4.      North America

6.4.1. Market Assessment and Forecast, By Country, 2014-2023($Million)

6.4.2. Market Assessment and Forecast, By Service, 2014-2023($Million)

6.4.3. Market Assessment and Forecast, By End User, 2014-2023($Million)

6.4.4. U.S.

6.4.4.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.4.4.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.4.5. Canada

6.4.5.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.4.5.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.4.6. Mexico

6.4.6.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.4.6.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.5.      Europe

6.5.1. Market Assessment and Forecast, By Country, 2014-2023($Million)

6.5.2. Market Assessment and Forecast, By Service, 2014-2023($Million)

6.5.3. Market Assessment and Forecast, By End User, 2014-2023($Million)

6.5.4. Germany

6.5.4.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.5.4.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.5.5. France

6.5.5.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.5.5.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.5.6. UK

6.5.6.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.5.6.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.5.7. Italy

6.5.7.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.5.7.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.5.8. Spain

6.5.8.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.5.8.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.5.9. Rest of Europe

6.5.9.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.5.9.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.6.      Asia-Pacific

6.6.1. Market Assessment and Forecast, By Country, 2014-2023($Million)

6.6.2. Market Assessment and Forecast, By Service, 2014-2023($Million)

6.6.3. Market Assessment and Forecast, By End User, 2014-2023($Million)

6.6.4. Japan

6.6.4.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.6.4.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.6.5. China

6.6.5.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.6.5.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.6.6. Australia

6.6.6.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.6.6.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.6.7. India

6.6.7.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.6.7.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.6.8. South Korea

6.6.8.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.6.8.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.6.9. Rest of Asia-Pacific

6.6.9.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.6.9.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.7.      Rest of the World

6.7.1. Market Assessment and Forecast, By Country, 2014-2023($Million)

6.7.2. Market Assessment and Forecast, By Service, 2014-2023($Million)

6.7.3. Market Assessment and Forecast, By End User, 2014-2023($Million)

6.7.4. Brazil

6.7.4.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.7.4.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.7.5. Turkey

6.7.5.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.7.5.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.7.6. Saudi Arabia

6.7.6.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.7.6.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.7.7. South Africa

6.7.7.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.7.7.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.7.8. United Arab Emirates

6.7.8.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.7.8.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

6.7.9. Others

6.7.9.1.   Market Assessment and Forecast, By Service, 2014-2023($Million)

6.7.9.2.   Market Assessment and Forecast, By End User, 2014-2023($Million)

7.      Company Profiles

7.1.      Envigo Corporation

7.1.1. Business Overview

7.1.2. Product Portfolio

7.1.3. Key Financials

7.1.4. Strategic Developments

7.2.      MPI research

7.2.1. Business Overview

7.2.2. Product Portfolio

7.2.3. Key Financials

7.2.4. Strategic Developments

7.3.      Eurofins Scientific

7.3.1. Business Overview

7.3.2. Product  Portfolio

7.3.3. Key Financials

7.3.4. Strategic Developments

7.4.      PRA Health Sciences, Inc

7.4.1. Business Overview

7.4.2. Product Portfolio

7.4.3. Key Financials

7.4.4. Strategic Developments

7.5.      Wuxi AppTec

7.5.1. Business Overview

7.5.2. Product Portfolio

7.5.3. Strategic Developments

7.6.      Medpace, Inc.

7.6.1. Business Overview

7.6.2. Product Portfolio

7.6.3. Strategic Developments

7.7.      Pharmaceutical Product Development (PPD), LLC

7.7.1. Business Overview

7.7.2. Product Portfolio

7.7.3. Strategic Developments

7.8.      PARAXEL International Corporation

7.8.1. Business Overview

7.8.2. Product  Portfolio

7.8.3. Strategic Developments

7.9.      ICON Plc.

7.9.1. Business Overview

7.9.2. Product  Portfolio

7.9.3. Strategic Developments

7.10.   Laboratory Corporation of America, Inc.

7.10.1.    Business Overview

7.10.2.    Product Portfolio

7.10.3.    Key Financials

7.10.4.    Strategic Developments


List of Tables

Table: Global Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Bioanalysis and DMPK studies Market, By Region, 2014-2023($Million)

Table: Toxicology testing Market, By Region, 2014-2023($Million)

Table: Other preclinical services Market, By Region, 2014-2023($Million)

Table: Global Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Biopharmaceutical companies Market, By Region, 2014-2023($Million)

Table: Government and academic institutes Market, By Region, 2014-2023($Million)

Table: Medical device companies Market, By Region, 2014-2023($Million)

Table: North America Preclinical CRO Market, By Country, 2014-2023($Million)

Table: North America Preclinical CRO Market, By Service, 2014-2023($Million)

Table: North America Preclinical CRO Market, By End User, 2014-2023($Million)

Table: U.S. Preclinical CRO Market, By Service, 2014-2023($Million)

Table: U.S. Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Canada Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Canada Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Mexico Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Mexico Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Europe Preclinical CRO Market, By Country, 2014-2023($Million)

Table: Europe Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Europe Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Germany Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Germany Preclinical CRO Market, By End User, 2014-2023($Million)

Table: France Preclinical CRO Market, By Service, 2014-2023($Million)

Table: France Preclinical CRO Market, By End User, 2014-2023($Million)

Table: UK Preclinical CRO Market, By Service, 2014-2023($Million)

Table: UK Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Italy Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Italy Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Spain Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Spain Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Rest of Europe Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Rest of Europe Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Asia-Pacific Preclinical CRO Market, By Country, 2014-2023($Million)

Table: Asia-Pacific Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Asia-Pacific Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Japan Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Japan Preclinical CRO Market, By End User, 2014-2023($Million)

Table: China Preclinical CRO Market, By Service, 2014-2023($Million)

Table: China Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Australia Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Australia Preclinical CRO Market, By End User, 2014-2023($Million)

Table: India Preclinical CRO Market, By Service, 2014-2023($Million)

Table: India Preclinical CRO Market, By End User, 2014-2023($Million)

Table: South Korea Preclinical CRO Market, By Service, 2014-2023($Million)

Table: South Korea Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Rest of Asia-Pacific Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Rest of Asia-Pacific Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Rest of the World Preclinical CRO Market, By Country, 2014-2023($Million)

Table: Rest of the World Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Rest of the World Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Brazil Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Brazil Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Turkey Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Turkey Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Saudi Arabia Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Saudi Arabia Preclinical CRO Market, By End User, 2014-2023($Million)

Table: South Africa Preclinical CRO Market, By Service, 2014-2023($Million)

Table: South Africa Preclinical CRO Market, By End User, 2014-2023($Million)

Table: United Arab Emirates Preclinical CRO Market, By Service, 2014-2023($Million)

Table: United Arab Emirates Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Others Preclinical CRO Market, By Service, 2014-2023($Million)

Table: Others Preclinical CRO Market, By End User, 2014-2023($Million)

Table: Envigo Corporation: Key Strategic Developments, 2015-2017

Table: MPI research: Key Strategic Developments, 2015-2017

Table: Eurofins Scientific: Key Strategic Developments, 2015-2017

Table: PRA Health Sciences, Inc: Key Strategic Developments, 2015-2017

Table: Wuxi AppTec: Key Strategic Developments, 2015-2017

Table: Medpace, Inc.: Key Strategic Developments, 2015-2017

Table: Pharmaceutical Product Development (PPD), LLC: Key Strategic Developments, 2015-2017

Table: PARAXEL International Corporation: Key Strategic Developments, 2015-2017

Table: ICON Plc: Key Strategic Developments, 2015-2017

Table: Laboratory Corporation of America, Inc.: Key Strategic Developments, 2015-2017


List of Figures

Figure: Global Preclinical CRO Market Share, By Service, 2014 & 2023

Figure: Global Preclinical CRO Market, By End User, 2014 & 2023 ($Million)

Figure: Global Preclinical CRO Market, By Region, 2014 & 2023 ($Million)

Figure: Envigo Corporation: Net Revenues, 2014-2016 ($Million)

Figure: Envigo Corporation: Net Revenue Share, By Segment, 2016

Figure: Envigo Corporation: Net Revenue Share, By Geography, 2016

Figure: MPI research: Net Revenues, 2014-2016 ($Million)

Figure: MPI research: Net Revenue Share, By Segment, 2016

Figure: MPI research: Net Revenue Share, By Geography, 2016

Figure: Eurofins Scientific: Net Revenues, 2014-2016 ($Million)

Figure: Eurofins Scientific: Net Revenue Share, By Segment, 2016

Figure: Eurofins Scientific: Net Revenue Share, By Geography, 2016

Figure: PRA Health Sciences, Inc: Net Revenues, 2014-2016 ($Million)

Figure: PRA Health Sciences, Inc: Net Revenue Share, By Segment, 2016

Figure: PRA Health Sciences, Inc: Net Revenue Share, By Geography, 2016

Figure: Laboratory Corporation of America, Inc.: Net Revenues, 2014-2016 ($Million)

Figure: Laboratory Corporation of America, Inc.: Net Revenue Share, By Segment, 2016

Figure: Laboratory Corporation of America, Inc.: Net Revenue Share, By Geography, 2016

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*